Automated Multiplex CRISPR-CasPhi (Cas12j) Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic sub-700aa bacteriophage-derived CasPhi (Cas12j) non-viral synthetic lipid nanoparticle (LNP) packaging cleanroom suites, $620/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CasPhi Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CasPhi Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation